Exploring high dose rate radiation therapy for cancer treatment
Preclinical optimization of ultra-high dose rate (FLASH) radiotherapy parameters for translational relevance
This study is exploring a new type of radiation therapy called FLASH that could help cancer patients by effectively targeting tumors while causing less harm to healthy tissues, and it aims to find the best ways to use this treatment for better results.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10907758 on NIH RePORTER |
What this research studies
This research investigates the use of ultra-high dose rate radiation therapy, known as FLASH radiotherapy, as a potential breakthrough treatment for cancer patients. The approach aims to maintain effective tumor control while significantly reducing damage to normal tissues compared to conventional radiation therapy. By analyzing the effects of different radiation parameters and their impact on tumor responses, the study seeks to optimize treatment protocols that could improve patient outcomes. The research will involve preclinical models to evaluate the effectiveness and safety of FLASH therapy across various organ systems.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are undergoing radiation therapy and may benefit from improved treatment options.
Not a fit: Patients with non-cancerous conditions or those who are not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments with fewer side effects for patients.
How similar studies have performed: Previous studies have shown promising results with FLASH radiotherapy, but this research aims to provide more comprehensive comparisons and insights into its effectiveness.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Schueler, Emil — University of Tx Md Anderson Can Ctr
- Study coordinator: Schueler, Emil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.